Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

ASE establishes vocabulary for cardiac POCUS to promote consistency

As cardiac point-of-care ultrasound use continues to grow outside of traditional echo labs, the American Society of Echocardiography is working to ensure everyone is on the same page.

Banner ASC in Sun City, Arizona.

Women urged to overcome radiation fears, consider a career in interventional cardiology

"The underrepresentation of women in interventional cardiology is a significant concern," according to one cardiologist behind the new campaign. 

PHOTO GALLERY: ASNC2024, the American Society of Nuclear Cardiology's annual meeting

The three-day event attracted nuclear cardiology specialists from all over the world.

Royal Philips has received U.S. Food and Drug Administration (FDA) approval for its new 160-cm LumiGuide endovascular navigation wire, which uses the company’s popular Fiber Optic RealShape (FORS) technology to deliver real-time 3D visualization without the use of fluoroscopy.

FDA approves longer LumiGuide 3D navigation wire from Philips

The newly approved device comes in at 160 cm. Like the shorter LumiGuide device from Philips, it was designed to deliver real-time 3D visualization with light instead of X-rays. 

IVUS Intravascular Ultrasound ACC

Intravascular imaging during PCI: Should cardiologists choose IVUS or OCT?

Which modality should care teams choose for PCI guidance? While there's an argument to be made for choosing IVUS over OCT, some specialists think the two treatment options are close to equal in terms of patient outcomes. 

SpectraWAVE, a Massachusetts-based imaging company focused on treatments for patients with coronary artery disease (CAD), has closed a $50 million funding round. Johnson & Johnson Innovation led the round, and other participants included S3 Ventures, Lumira Ventures, SV Health Investors, Deerfield Management, NovaVenture and Heartwork Capital.

SpectraWAVE raises $50M for FDA-cleared intravascular imaging technology

The funds, including a significant investment from Johnson & Johnson, are expected to go toward expanding access to the company's HyperVue Imaging System and exploring new features.

Cardiac PET on the rise among U.S. cardiologists

SPECT is still the most common modality used to evaluate CAD patients, but cardiac PET is gaining more and more momentum.

SCCT 2024-2025 President Maros Ferencik (right) shared an office with SCCT's first president Stephan Achenbach (left) in 2002.

New SCCT president takes office, lists priorities

Maros Ferencik, MD, noted that the Society of Cardiovascular Computed Tomography represents specialists from many different specialties, including cardiology, radiology and beyond. 

Displaying 33 - 40 of 1775

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.